A pdf file with the requested content has been emailed to you.
***DO NOT REPLY TO THIS EMAIL***
Dear Sir/Madam:
Thank you for your interest in the EMD Serono, Inc. Medical Resource Website. Attached you will find a copy of the MAVENCLAD Prescribing Information.pdf you requested. If articles are supplied to you in response to your unsolicited request they may be protected by copyright law (Title 17 U.S. Code).
The physician payment reporting provisions of the Patient Protection and Affordable Care Act of 2010 (the "Sunshine Provisions") require that all applicable manufacturers, including EMD Serono, Inc., track and report to the Centers for Medicare & Medicaid Services (CMS) all transfers of value to US physicians, specifically including the value of journal reprints.
EMD Serono, Inc. provides information to healthcare professionals as part of its commitment to research and therapy. If this document contains information outside of the product labeling approved by the US Food and Drug Administration, it is not intended to suggest or recommend any indication, dosage, or other claim not covered in our product package insert. It is meant to provide pertinent data to assist you in forming your own interpretations. Please consult the full prescribing information before using or prescribing any product of EMD Serono, Inc. If published articles are cited, summarized, listed in a literature search, and/or enclosed in this response, the views and opinions expressed by the authors do not necessarily represent the opinions of EMD Serono, Inc. This response may not represent a comprehensive listing of all available publications on this subject.
Should you have any further questions please contact the US Medical Information Contact Center at 1-888-275-7376 (Monday-Friday, 8 AM - 5:30 PM EST) or submit your question online at http://medinfo.emdserono.com.
US Medical
EMD Serono, Inc. | One Technology Place | Rockland, MA 02370 | USA
Phone: +1 888 275 7376 | Fax: +1 781 681 2907
Website: http://www.emdserono.com/
EMD Serono, Inc. is a subsidiary of Merck KGaA Darmstadt, Germany
If the email didn't arrive, please check your spam folder.
A pdf file with the requested content has been emailed to you.
If the email didn’t arrive, please check your spam folder. The pdf has been sent to the email address you provided upon registration:
MAVENCLAD, Rebif, Rebif Rebidose and MS LifeLines are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
If this time frame does not satisfy any specific urgency you may have with your request, please contact us at 1-888-275-7376
Please expect our call within 15 minutes of your specified time.
CLOSE